Selective immunosuppression with daclizumab in liver transplantation with graft-versus-host disease

Transplant Proc. 2002 Feb;34(1):109-10. doi: 10.1016/s0041-1345(01)02828-7.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antibody-Dependent Cell Cytotoxicity
  • Antigens, CD / blood
  • Daclizumab
  • Graft vs Host Disease / drug therapy*
  • Herpesvirus 6, Human / isolation & purification
  • Humans
  • Immunoglobulin G / therapeutic use*
  • Immunosuppressive Agents / therapeutic use*
  • Liver Cirrhosis, Alcoholic / surgery
  • Liver Transplantation / immunology*
  • Lymphocyte Count
  • Lymphocytes / drug effects
  • Lymphocytes / immunology
  • Male
  • Middle Aged
  • Receptors, Interleukin-2 / analysis
  • Roseolovirus Infections / diagnosis
  • T-Lymphocytes / immunology

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antigens, CD
  • Immunoglobulin G
  • Immunosuppressive Agents
  • Receptors, Interleukin-2
  • Daclizumab